Across the EU, cannabinoid extracts including cannabinol are classified as unauthorised novel foods under Regulation (EU) 2015/2283, and no Union list authorisation exists in any member state.

The Danish food authority's wording is class-level rather than cannabidiol-specific: extracts of the hemp plant and derived products containing cannabinoids are novel foods, as are extracts of other cannabinoid-containing plants and synthetically produced cannabinoids. Every route by which cannabinol could be produced falls inside that. There is no lawful food or food supplement route for cannabinol in Denmark.

Cannabinol is not named as a euphoriant substance. It appears nowhere in the lists annexed to the current order on euphoriant substances, as verified against the operative text of the instrument rather than an agency summary of it. Denmark has added semi-synthetic cannabinoids individually and in family groups through amendments in 2024, 2025 and 2026, and cannabinol was not among them on any occasion.

Denmark does operate a generic group entry covering compounds structurally derived from the hexahydrocannabinol scaffold by the addition of a double bond in one ring. On our reading cannabinol falls outside it, because the corresponding ring in cannabinol is fully aromatic rather than carrying a single added double bond. That is our reading of the wording, not a position any Danish authority has published, and we treat it as open.

As with cannabidiol, the medicines route applies independently: an oral cannabinoid product with pharmacological effect can be classified a medicine on a product-by-product basis, with no dose threshold.